Gene Mutation and Endometrial Cancer Greenville NC

A genetic marker for aggressive endometrial cancer has been identified by U.S. researchers, who said their finding could lead to more targeted and risk-appropriate treatments. The researchers, from the Washington University School of Medicine in St. Louis, found that genetic mutation of the ATR gene in tumors boosts the risk of cancer recurrence and death in women#r3 with a highly aggressive form of the disease known as endometrioid endometrial cancer.

Greenville Veterinary Hospital
(252) 752-1890
1523 East 14th Street
Greenville, NC

Data Provided by:
Midesha Pillay
(252) 744-3258
1204 E Fire Tower Rd
Greenville, NC
Specialty
Family Practice, Geriatric Medicine

Data Provided by:
Teresa A Smith
(252) 353-1464
1688 E Arlington Blvd
Greenville, NC
Specialty
Internal Medicine

Data Provided by:
Judith Salle Yongue, MD
(252) 355-2768
107 Commerce St Ste D
Greenville, NC
Specialties
Psychiatry, General Practice
Gender
Female
Education
Medical School: Univ Of Nc At Chapel Hill Sch Of Med, Chapel Hill Nc 27599
Graduation Year: 1962
Hospital
Hospital: Pitt County Memorial Hospital, Greenville, Nc
Group Practice: Judith Yongue Psychiatric Med

Data Provided by:
Sylvia J Mullis
(252) 355-4357
1913 E Fire Tower Rd
Greenville, NC
Specialty
Family Practice

Data Provided by:
Charles E Jahrsdorfer
(252) 756-3713
3282 Charles Blvd
Greenville, NC
Specialty
Family Practice

Data Provided by:
Kelly W Philpot
(252) 744-1122
1204 E Fire Tower Rd
Greenville, NC
Specialty
Family Practice

Data Provided by:
Angela B Mebane
(252) 744-1122
1204 E Fire Tower Rd
Greenville, NC
Specialty
Family Practice

Data Provided by:
John Edward Siegel
(252) 328-6841
1001 E. Fifth St.
Greenville, NC
Specialty
Family Practice, Sports Medicine

Data Provided by:
Shirley T Williamson
(252) 328-6841
1001 East 5th Street
Greenville, NC
Specialty
General Practice, Family Practice

Data Provided by:
Data Provided by:

Gene Mutation and Endometrial Cancer

Provided By:

WEDNESDAY, May 27 (HealthDay News) -- A genetic marker for aggressive endometrial cancer has been identified by U.S. researchers, who said their finding could lead to more targeted and risk-appropriate treatments.

The researchers, from the Washington University School of Medicine in St. Louis, found that genetic mutation of the ATR gene in tumors boosts the risk of cancer recurrence and death in women with a highly aggressive form of the disease known as endometrioid endometrial cancer.

The ATR gene directs cellular responses to DNA damage, the researchers noted.

"Women whose endometrial cancers have an ATR mutation have more than four times the risk of having their cancer return," study author Dr. Israel Zighelboim, a gynecologic oncologist, said in a news release from the university. "This and similar tumor biomarkers could potentially identify those patients most in danger of recurrence and guide the development of treatments aimed at these more aggressive tumors."

ATR mutations were found in about 5 percent of the 248 endometrioid endometrial tumor samples analyzed by the researchers. Women with ATR mutations were 4.29 times more likely to have the cancer recur after treatment and 3.88 times more likely to die.

The study appears online in the Journal of Clinical Oncology.

Zighelboim and his research colleagues plan to see if the prognostic value of ATR mutations can be confirmed in a larger group of women and to investigate the association between ATR mutations and treatment response after cancer recurrence.

More information

The American Cancer Society has more about endometrial cancer.

SOURCE: Washington University School of Medicine in St. Louis, news release, May 26, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com